SIMS LIMITED — Director's Dealing 2025

May 6, 2025

7 May 2025

The Manager Market Announcements Office ASX Limited Level 4, Bridge Street SYDNEY NSW 2000 Sims Limited

(ASX: SGM) - APPENDIX 3Y

Dear Sir/Madam,

The enclosed Appendix 3Y reports the number of options exercised by Mr Mikkelson on 2 May 2025 and the corresponding sale of the shares on the same date. It also reports the grant of 202,311 performance shares on 14 November 2024 following shareholder approval and the lapse of 55,168 options that expired on 5 February 2025 in accordance with their terms and conditions. Due to administrative oversight, the Company did not lodge the required Appendix 3Y documentation. As soon as the oversight was identified the Appendix 3Y was lodged with the ASX. The Company and the Directors are aware of their obligations under ASX Listing Rule 3.19A and 3.19B. The Company has a Securities Trading Policy in place which sets out the requirements to notify the Company of changes in interests and believes that its current practices are adequate to ensure compliance with the ASX Listing Rules.

Yours Sincerely,

==> picture [128 x 41] intentionally omitted <==

Gretchen Johanns

Company Secretary

Appendix 3Y

Change of Director’s Interest Notice

Rule 3.19A.2

APPENDIX 3Y

CHANGE OF DIRECTOR’S INTEREST NOTICE

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity SIMS LIMITED ABN 69 114 838 630

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

NAME OF DIRECTOR	STEPHEN MIKKELSEN
Date of last notice	10 October 2024

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest

Direct and Indirect

• See chapter 19 for defined terms.

Appendix 3Y Page 1

01/01/2011

Appendix 3Y

Change of Director’s Interest Notice

Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	The ordinary shares acquired are held for the benefit of Mr Mikkelsen by the registered holder HSBC Custody Nominees (Australia) Limited – A/C 2 on behalf of Morgan Stanley Smith Barney LLC, which company provides services in connection with the entity’s global employee share plan.
Date of change	5 February 2025 and 2 May 2025

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y

Change of Director’s Interest Notice

No. of securities held prior to change		Direct Interest 4,600 ordinary shares 215,387 Performance Rights 55,168 Options @17.10 expire 5/02/2025 99,933 Options @12.34 expire 9/11/2025 Indirect Interest 134,522ordinary shares Includes 16,599 ordinary shares that are subject to a holding period (11,316 ordinary shares are released on 31/8/2025 and 5,283 ordinary shares are released on 31/8/2026).
Class		(1) Performance Rights (2) Ordinary Shares (3) Options

• See chapter 19 for defined terms.

Appendix 3Y Page 3

01/01/2011

Appendix 3Y

Change of Director’s Interest Notice

Number acquired	(1) 202,311 Performance Rights (2) 9,425 Ordinary Shares
Number disposed	(1) 9,425 Ordinary Shares (2) 99,933 Options @12.34 expire on 9/11/2025 (3) 55,168 Options @17.10 expire on 5/02/2025
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Ordinary shares sold at an average price of $14.62 per share.

• See chapter 19 for defined terms.

Appendix 3Y Page 4

01/01/2011

Appendix 3Y

Change of Director’s Interest Notice

No. of securities held after change		Direct Interest 4,600 ordinary shares 417,698 Performance Rights Indirect Interest 134,522 ordinary shares Includes 16,599 ordinary shares that are subject to a holding period (11,316 ordinary shares are released on 31/8/2025 and 5,283 ordinary shares are released on

• See chapter 19 for defined terms.

Appendix 3Y Page 5

01/01/2011

Appendix 3Y

Change of Director’s Interest Notice

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

• (1) Receipt of 202,311 Performance Shares on 14 November 2024 following shareholder approval at the Annual General Meeting.

• (2) Sale of 9,425 ordinary shares received from the exercise of the 99,933 Options@12.34.

• (3) Exercise of 99,933 Options @12.34 that were scheduled to expire on 9/11/2025.

• (4) Expiration of 55,168 Options @17.10 on 05/02/2025.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 6

01/01/2011

Appendix 3Y

Change of Director’s Interest Notice

Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?
If prior written clearance was provided, on what date was this provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 7

01/01/2011

Appendix 3Y

Change of Director’s Interest Notice

• See chapter 19 for defined terms.

Appendix 3Y Page 8

01/01/2011